This topic contains a solution. Click here to go to the answer

Author Question: According to the developmental model of relapse prevention, the following stage is considered the ... (Read 181 times)

justinmsk

  • Hero Member
  • *****
  • Posts: 524
According to the developmental model of relapse prevention, the following stage is considered the beginning stage of treatment and involves the solving of immediate problems:
 
  (a) Stabilization
   (b) Transition
   (c) Early recovery
   (d) Maintenance

Question 2

Which of the following is considered an appropriate limit on client alcohol use post-treatment:
 
  a) The client should drink no more than once or twice per week
  b) The client should drink no more than once or twice per month
  c) The client may drink only occasionally (i.e., a few times per year)
  d) The client should commit to complete abstinence



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

al

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

A

Answer to Question 2

D





 

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library